poisar

Stock

Nexalin Technology, Inc. NXL

$0.35+0.49%

Overview

NXL market data

Price History

NXL price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.50
Diluted earnings per share over the trailing twelve months.
Beta
4.03
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-3,022.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.31 – $2.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $7.7M · P/B 9.66 · P/S 27.99.

Company News

6 captured
8-K filing — Nexalin Technology, Inc. (NXL)SEC EDGAR · Jul 29, 2026, 9:25 PM
Nexalin Technology To Present Clinical Data Showing 77.8% Anxiety Response Rate, Durable 8-Week Benefits, And No Serious Adverse Events From Its 15 mA, 77.5 Hz DIFS Deep-Brain Stimulation Platform, At 2026 NYC Neuromodulation ConferenceBenzinga · Jun 16, 2026, 1:25 PM
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and InsomniaGlobenewswire Inc · Jun 4, 2026, 2:15 PM
Nexalin Technology Announces New U.S. Patent Covering Dynamic Frequency Deep-Brain Neurostimulation For Anxiety, Depression, And Insomnia TreatmentBenzinga · Jun 4, 2026, 2:05 PM
Nexalin Technology Secures Key Neurostimulation Legislative Provision In Appropriations Bill Passed By U.S. House Of RepresentativesBenzinga · May 21, 2026, 12:40 PM
Nexalin Technology Acquires Digital Health Platform PONM From GreenLight Ventures; Financial Terms Not DisclosedBenzinga · May 19, 2026, 12:40 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock